Targeting a key enzyme to improve treatment for glioblastoma
Targeting OGDH for Glioblastoma Therapy
This study is looking at how a special enzyme called OGDH affects glioblastoma, a tough-to-treat brain tumor, and is testing a new drug that could make current treatments work better and help patients live longer.
Quick facts
| Grant type | R21 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Columbia University Health Sciences NIH-funded |
| Lab location | 1 site (New York, United States) |
| Project ID | NIH-11074554 on NIH RePORTER |
What this research studies
This research focuses on glioblastoma, a highly aggressive brain tumor that is difficult to treat. The team has discovered that a specific enzyme, OGDH, plays a crucial role in the growth of these tumors. By using a drug that inhibits OGDH, they aim to enhance the effectiveness of existing treatments and potentially improve patient survival. The research involves detailed laboratory studies and analyses to understand how this approach can be applied in clinical settings.
Who could benefit from this research
Good fit: Ideal candidates for this research are adults diagnosed with glioblastoma who are seeking new treatment options.
Not a fit: Patients with other types of brain tumors or those who are not diagnosed with glioblastoma may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to more effective treatments for glioblastoma, potentially extending survival and improving quality of life for patients.
How similar studies have performed: Previous research has shown promising results using similar approaches to target metabolic pathways in cancer treatment, indicating potential for success in this area.
Where this research is happening
New York, United States
- Columbia University Health Sciences — New York, United States (Active)
Researchers
- Principal investigator: Siegelin, Markus D — Columbia University Health Sciences
- Study coordinator: Siegelin, Markus D
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.